Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 5-(Hydroxymethyl)uracil

5-(Hydroxymethyl)uracil

5-(Hydroxymethyl)uracil structure

5-(Hydroxymethyl)uracil 

structure
  • CAS No:

    4433-40-3

  • Formula:

    C5H6N2O3

  • Chemical Name:

    5-(Hydroxymethyl)uracil

  • Synonyms:

    2,4(1H,3H)-Pyrimidinedione,5-(hydroxymethyl)-;Uracil,5-(hydroxymethyl)-;5-(Hydroxymethyl)-2,4(1H,3H)-pyrimidinedione;5-(Hydroxymethyl)uracil;α-Hydroxythymine;NSC 20901;5-(Hydroxymethyl)-1,3-dihydropyrimidine-2,4-dione;5-Hydroxymethyl-1H-pyrimidine-2,4-dione

  • Categories:

    Pharmaceutical Intermediates  >  Bulk Drug Intermediates

Description

5-Hydroxymethyluracil is a product of oxidative DNA damage. 5-Hydroxymethyluracil can be used as a potential epigenetic mark enhancing or inhibiting transcription with bacterial RNA polymerase.


Solid


5-hydroxymethyluracil is a primary alcohol that is uracil bearing a hydroxymethyl substituent at the 5-position. It has a role as a human metabolite. It is a primary alcohol and a pyrimidone. It derives from a uracil.

5-(Hydroxymethyl)uracil Basic Attributes

142.11

142.11

224-636-5

590TQ3GL34

20901

DTXSID9063455

2933599090

Characteristics

78.4

-1.9

Solid

1.4±0.1 g/cm3

195-200 °C

530.4°C at 760 mmHg

274.6ºC

1.528

Soluble in water. (50 g/L ) at 20°C, DMSO, dimethyl formamide or 100% ethanol.

Refrigerator

119.21 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|142.06 Ų [M+Na]+ [CCS Type: DT, Method: stepped-field]|124.5 Ų [M-H]- [CCS Type: DT, Method: stepped-field]|124.1 Ų [M-H]-

Safety Information

NONH for all modes of transport

3

S22-S24/25

YR0513000

Xi: Irritant;

P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501

H315

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 2 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)|Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)

5-hydroxymethyluracil

5-(Hydroxymethyl)uracil Use and Manufacturing

Methods of Manufacturing

To a mixture of 1H-pyrimidine-2, 4-dione (20 g, 178.4 mmol) in aqueous solution of potassium hydroxide (8.0 g, 142.7 mmol) in water (160.0 mL), paraformaldehyde (6.96 g, 231.9 mmol) was added portion-wise at 0° C. The resulting reaction mixture was stirred at 55° C. for 36 h. After completion, the reaction was cooled to room temperature and concentrated to A suspension of uracil (2.5 g, 22.3 mmol) and para-formaldehyde (2.0 g, 66.9 mmol) in H2O (75 mL)was treated with NEt3 (4.6 mL, 33.4 mmol) and heated with stirring at 60 °C for 16 h. The mixture wasrotary evaporated, and the residue triturated with H2O and EtOH (1:1, 20 mL), stirred for 1 h at 0 °C, filtered and washed with cold EtOH to yield 5-hydroxymethyluracil (20) (2.3 g, 73 percent) as a white solidA mixture of uracil (3.6 g, 32.1 mmol), formaldehyde (37percent in water) (3.25 ml), KOH (1.4 g, 25 mmol) in water (45 ml) was stirred at 50° C. for 20 h. The reaction was acidified with 1 N HCl to give a white precipitate. The solids were collected dried under vacuum to give the 5-(hydroxymethyl)-2, 4(1H, 3H)-pyrimidinedione (2.01 g, 44percent) as a white solid.Uracil (10.0 g, 89.2 mmol, 1.0 eq.) and paraformaldehyde (3.24 g, 107 mmol, 1.2 eq.) were treated with KOH (0.5 M, 133 ml) and the mixture heated at 50 °C for 8 hours 30 minutes, stirred at rt for 64 hours then heated at 50°C for 24 hours. The mixture was cooled to 0°C in an ice bath and acidified to pH 6 with HC1 (conc). The precipitate wasfiltered off, washed with water and oven dried providing the title compound (4.93 g, 39percent) as a white solid.‘HNMR (400 MHz, DMSO)6 11.05 (s, IH), 10.71 (s, 1H), 7.24(s, IH), 4.85 (t, J=5.5 Hz, 1H), 4.11 (dd, J 5.5, 1.1 Hz, 2H). Rf = 0.10 (50:8:1 DCM:EtOH:NH3)Intermediate 1 [00353j A 1-L, three-necked flask equipped with a mechanical stirrer, was charged with uracil (45.0 g, 401 mmol) and paraformaldehyde (14.5 g, 483 mmol). A solution of potassium hydroxide (0.5 M, 600 mL, 0.30 mol) was added in one portion. The resulting mixture was stirred at 55 °C overnight. The mixture was cooled in an ice-water bath and the pH was adjusted to 6 with 12 N HC1. The resulting precipitate was collected by filtration and dried to afford the title compound (46.0 g) as a white solid which was used in the next step without further purification. ‘H NMR (400 MHz, DMSO-d6): ö 4.12 (d, 2H), 4.78 (t, 1H), 7.24 (s, 1H), 10.64 (s, 1H), 10.98 (s, 1H).(2) Uracil (13.5 g, 100 mmol) and paraformaldehyde (4.5 g, 120 mmol) were dissolved in 150 mL of 0.5 mol / L After the potassium hydroxide solution was stirred for half an hour, it was stirred in a water bath at 52 ° C for about 20 hours. The thin layer analysis showed that the raw material completely disappeared. Most of the water is removed with a rotary evaporator so that the inner volume of the flask is approximately 1/3 of the original volume, After adding an equal amount of acetone recrystallized at 0 ~ 5 °C , 3 hours, suction filtration, washing, pumping dry, vacuum drying, weighing. Product is a white solid 16.26g

2,4(1H,3H)-Pyrimidinedione, 5-(hydroxymethyl)-: INACTIVE

Computed Properties

Molecular Weight:142.11
XLogP3:-1.9
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:1
Exact Mass:142.03784206
Monoisotopic Mass:142.03784206
Topological Polar Surface Area:78.4
Heavy Atom Count:10
Complexity:209
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of 5-(Hydroxymethyl)uracil

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.